Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02863887 · ClinicalTrials.gov registry record · NA

Lifestyle Changes Through Exercise and Nutrition

A NA study of Obesity and Diabetes, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
97
Enrollment target
1
Study location

NCT02863887: Completed NA study of Obesity and Diabetes, sponsored by Pennington Biomedical Research Center.

NCT02863887 is a NA study of Obesity and Diabetes that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 97 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02863887, a NA study of Obesity and Diabetes, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target
1
Study location

Study Summary

The goal of The LEAN project intervention is to promote weight loss, healthy dietary habits, increased physical activity, improved blood glucose and cholesterol, and weight related quality of life in obese African American adults through a sustainable, technology enhanced, church-based program.

Primary Outcome

Percent weight loss will be calculated at 6 and 12 months.

Conditions Studied

Interventions

  • BEHAVIORAL Weight loss intervention

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2016-06
Est. Completion 2017-09-23
Phase NA

What the finished NCT02863887 record still lists

NCT02863887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Weight loss intervention is the first listed.

NCT02863887 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT02863887 about?

NCT02863887 is a clinical study titled "Lifestyle Changes Through Exercise and Nutrition". The goal of The LEAN project intervention is to promote weight loss, healthy dietary habits, increased physical activity, improved blood glucose and cholesterol, and weight related quality of life in obese African American adults through a sustainable, technology enhanced, church-based program.

What is the current status of trial NCT02863887?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2016-06. Estimated completion is 2017-09-23.

What conditions does trial NCT02863887 study?

This clinical trial studies the following conditions: Obesity, Diabetes.

What interventions are being tested in trial NCT02863887?

The interventions under investigation include: Weight loss intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02863887?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02863887 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02863887's enrollment target sits among peer trials

97 502nd of 1053 higher than 551 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03948490 · 97 participants · NA

    Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

  • NCT04140487 · 97 participants · Phase 1

    Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

  • NCT04196413 · 97 participants · Phase 1

    GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

  • NCT05223816 · 97 participants · Phase 2

    An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02863887, the US trial registry maintained by the National Library of Medicine. NCT02863887 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.